Published in
American Society of Hematology, Blood Advances, 17(6), p. 5222-5226, 2022
DOI: 10.1182/bloodadvances.2022008093
Links
Tools
Low rate of subsequent malignant neoplasms after CD19 CAR T-cell therapy
Journal article published in 2022 by
Emily M. Hsieh 
,
Regina M. Myers ,
Bonnie Yates,
Colleen Annesley,
Samuel John,
Agne Taraseviciute,
Seth M. Steinberg,
Jennifer Sheppard,
Perry Chung,
Lee Chen,
Daniel W. Lee ,
Amanda DiNofia,
Stephan A. Grupp,
Michael R. Verneris,
Theodore W. Laetsch
and other authors.
,
Regina M. Myers ,
Bonnie Yates,
Colleen Annesley,
Samuel John,
Agne Taraseviciute,
Seth M. Steinberg,
Jennifer Sheppard,
Perry Chung,
Lee Chen,
Daniel W. Lee ,
Amanda DiNofia,
Stephan A. Grupp,
Michael R. Verneris,
Theodore W. Laetsch
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 